Dopamine, hypertension and obesity - Journal of Human Hypertension
- ️Velasco, M
- ️Wed Apr 24 2002
Luchsinger A et al. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensivepatients Int J Clin Pharmacol Therap 1995 33: 509–512
Martín G et al. Effect of intravenous dopamine on blood pressure and plasma insulin in hypertensivepatients Europ J Clin Pharmacol 1993 45: 503–505
Romero E, Velasco M, Luchsinger A . Dopamina e hipertensión arterial: implicaciones terapéuticas del uso de agonistas y antagonistas Arch Venez Farmacol Terap 1993 12: 158–163
Missale C et al. Dopamine receptors: from structure to function Physiol Rev 1998 78: 189–225
Tiberi M et al. Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor Proc Natl Acad Sci USA 1991 88: 7491–7495
Senogles SE . The D2s dopamine receptor stimulates phospholipase D activity: a novel signaling pathway for dopamine Mol Pharmacol 2000 58: 455–462
Cardinaud B et al. Early emergence of three dopamine D1 receptor subtypes in vertebrates J Biol Chem 1997 272: 2778–2787
Demchyshyn LL et al. The dopamine D1D receptor. Cloning and characterization of three pharmacologically distinct D1-like receptors from Gallus Domesticus J Biol Chem 1995 270: 4005–4012
Vernier P et al. An evolutionary view of drug-receptor interaction: the bioamine receptor family Trends Pharmacol Sci 1995 16: 375–381
O'Connel DP et al. Localization of dopamine D1A receptor protein in rat kidneys Am J Physiol (Renal Fluid Electrolyte Physiol) 1995 268: F1185–F1197
Luippold G et al. Postglomerular vasoconstriction induced by dopamine D3 receptor activation in anesthetized rats Am J Physiol (Renal Physiol) 2000 278: F570–F575
Mülbauer B, Küster E, Luippold G . Dopamine D3 receptors in the rat kidney: role in physiology and pathophysiology Acta Physiol Scand 2000 168: 219–223
Holtbäck U, Kruse MS, Brismar H, Aperia A . Intrarenal dopamine coordinates the effect of antinatriuretic and natriuretic factors Acta Physiol Scand 2000 168: 215–218
Aperia AC . Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism Ann Rev Physiol 2000 62: 621–647
Hussain T, Lokhandwala MF . Renal dopamine receptor function in hypertension Hypertension 1998 32: 187–197
Hansell P, Isaksson B, Jöquist MS . Renal dopamine and noradrenaline excretion during CNS-induced natriuresis in spontaneously hypertensive rats: influence of dietary sodium Acta Physiol Scand 2000 168: 257–266
Cheng HF, Becker BN, Harris RC . Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule J Clin Inves 1996 97: 2745–2752
Carranza A, Nowicki S, Barontini M, Armando I . L-Dopa uptake and dopamine production in proximal tubular cells are regulated by β2-adrenergic receptors Am J Physiol (Renal Physiol) 2000 279: F77–F83
Felder RA, Felder CC, Eisner GM, Jose PA . The dopamine receptor in adult and maturing kidney Am J Physiol (Renal Fluid Electrolyte Physiol) 1989 26: F315–F327
Li L, Schafer JA . Dopamine inhibits vasopressin-dependent cAMP production in the rat cortical collecting duct Am J Physiol (Renal Physiol) 1998 275: F62–F67
Sanada H et al. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension Hypertension 1999 33: 1036–1042
Hussain T, Abdul-Wahab R, Lokhandwala MF . Bromocriptine stimulates Na,K,ATPase in renal proximal tubules via camp pathway Eur J Pharmacol 1997 321: 259–263
Velasco M et al. Dopaminergic influence on the cardiovascular response to exercise in normotensive and hypertensive subjects Int J Clin Pharmacol 1995 33: 504–508
Albrecht FE et al. Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension J Clin Invest 1996 97: 2283–2288
O'Connell DP et al. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status Hypertension 1997 29: 115–122
Sato M, Soma M, Nakayama T, Kanmatsuse K . Dopamine D1 receptor gene polymorphism is associated with essential hypertension Hypertension 2000 36: 183–186
Felder RA, Eisner GM, Jose PA . D1 dopamine receptor signaling defect in spontaneous hypertension Acta Physiol Scand 2000 168: 245–250
Asico LD et al. Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension J Clin Invest 1998 102: 493–498
Schafer JA, Li L, Sun D . The collecting duct, dopamine and vasopressin-dependent hypertension Acta Physiol Scand 2000 168: 239–244
Sun D, Wilborn TW, Schafer JA . Dopamine D4 receptor isoform mRNA and protein are expressed in the rat cortical collecting duct Am J Physiol (Renal Physiol) 1998 275: F742–F751
Felder CC, Campbell T, Albrecht F, Jose PA . Dopamine inhibits Na+-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase Am J Physiol (Renal Fluid Electrolyte Physiol) 1990 259: F297–F303
Felder CC et al. cAmp-independent, G protein-linked inhibition of Na+/H+ exchange in renal brush border by D1 dopamine agonists Am J Physiol (Renal Fluid Electrolyte Physiol) 1993 264: F1032–F1037
Yu PY et al. Dopamine D1A receptor regulation of phospholipase C isoform J Biol Chem 1996 271: 19503–19508
Xu J et al. Dopamine1 receptor, Gsα, and Na+–H+ exchanger interactions in the kidney in hypertension Hypertension 2000 36: 395–399
Lucas-Texeira V, Serrão MP, Soares-Da-Silva P . Effect of salt intake on jejunal dopamine, Na+,K+-ATPase activity and electrolyte transport Acta Physiol Scand 2000 168: 225–231
Vieira-Coelho MA et al. Concerted action of dopamine on renal and intestinal Na+-K+-ATPase in the rat remnant kidney Am J Physiol (Renal Physiol) 2000 279: F1033–F1044
Nowicki S, Kruse MS, Brismar H, Aperia A . Dopamine-induced translocation of protein kinase C isoforms visualized in renal epithelial cells Am J Physiol (Cell Physiol) 2000 279: C1812–C1818
Yao LP et al. Dopamine D1 receptor and protein kinase C isoforms in spontaneously hypertensive rats Hypertension 1998 32: 1049–1053
Rossi NF . Dopaminergic control of angiotensin II-induced vasopressin secretion in vitro Am J Physiol (Endocrinol Metab) 1998 275: E687–E693
Healy DP, Jayaraman G, Ashirova O . Chemical hypoxia-induced increases in dopamine D1A receptor mRNA in renal epithelial cells are mediated by nitric oxide Acta Physiol Scand 2000 168: 233–238
Jose PA et al. Effects of costimulation of dopamine D1- and D2-like receptors on renal function Am J Physiol (Regulatory Integrative Comp Physiol) 1998 275: R986–R994
Murphy MB . Dopamine: a role in the pathogenesis and treatment of hypertension J Hum Hypertens 2000 14: s47–s50
Tumlin JA et al. Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial Academic Emergency Med 2000 7: 653–662
Mertens IL, Van Gaal LF . Overweight, obesity, and blood pressure: the effects of modest weight reduction Obesity Res 2000 8: 270–278
Wang G et al. Brain dopamine and obesity Lancet 2001 357: 354–357
Baptista T . Body weight gain induced by antipsychotic drugs: mechanisms and management Acta Psychiatr Scand 1999 100: 3–16
Volkow ND et al. Reinforcing effects of psychostimulants in humans are asociated with increases in brain dopamine and occupancy of D2 receptors J Pharm Exp Therap 1999 291: 409–415
Thomas GN, Tomlinson B, Critchley J . Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism Hypertension 2000 36: 177–182
Hussain T, Begheray SA, Lokhandwala MF . Defective dopamine receptor function in proximal tubules of obese Zucker rats Hypertension 1999 34: 1091–1096
Lokhandwala MF, Hussain T . Defective renal dopamine D1-like receptor signal transduction in obese hypertensive rats Acta Physiol Scand 2000 168: 251–255
Weed MR et al. The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys J Pharm Exp Therap 1997 283: 29–38